You Searched For "revlimid" and got 13 results
Sort By:
2 mins read
Rep. Katie Porter ripped into pharma executive Mark Alles for repeated price hikes on the cancer drug Revlimid
"The drug didn't get any better, the cancer patients didn't get any better, you just got better at …
Lauren Frias
2 mins read
Bristol Myers surges 10%, its biggest increase since 2008, after boosting profit forecast
Bristol Myers Squibb raised profit forecasts and beat revenue estimates amid strong sales for its b…
Kelly Cloonan
4 mins read
The medicine that is keeping my partner cancer-free put me at risk. No one told us if I got pregnant, the fetus could have severe complications.
The author's partner was diagnosed with cancer and put on a daily anti-cancer drug. Now she can't g…
Brianna Wilson
3 mins read
US outlook improves for Indian pharma but domestic market under the cloud
The Indian pharma sector has gone through many ups and downs in the last few years – like falling f…
1 min read
Top pharma stock movers — Lupin, Cipla, Dr Reddy’s steal the show
The Nifty Pharma index gained 2.82% during the early trading hour. Pharma stocks have been on a rol…
3 mins read
Here's why Bristol-Myers Squibb's record-breaking $74 billion biotech deal is facing investor backlash
"We now have six near-term launch opportunities, and I stress the term 'near-term' - a number of th…
Emma Court
3 mins read
Top stocks to watch — Future Retail, Power Grid, Cipla, Delta Corp, Yes Bank, Adani Power and others
Indian stock-market indices are likely to open on a higher note on Monday, led by positive cues fro…
3 mins read
Top stocks to watch— Dr Reddy's Laboratories, HDFC Bank, TVS Motor, Vedanta, IRCTC, L&T, Bharat Forge, HAL, and more
Indian stock market is likely to open on a tepid note, tracking subdued cues from global markets. A…
4 mins read
Congress is grilling little-known middlemen over the high cost of prescription drugs. Here's how they're defending themselves.
Instead, drug companies point to a measure called net price, which takes into account rebates and d…
Lydia Ramsey
2 mins read
Biotech giant Celgene is abandoning a drug it bought for $710 million - and the stock is dropping
The drug was being tested in late-stage and extension studies as a treatment for Crohn's, an autoim…
Lydia Ramsey,Reuters
2 mins read
The FDA just approved a drug that could revolutionize the way we treat a type of blood cancer
Empliciti will be used in combination with two other drugs to treat patients with multiple myeloma …
Lydia Ramsey
4 mins read
Kyle Bass eviscerates a drug company's criticism of him short selling their stock
"CFAD's IPRs are part of its investment strategy, and it will only succeed by invalidating pat…
Julia La Roche
8 mins read
10 surprises that could rock biotech stocks in 2019, from success in Alzheimer's to a stumble in depression
Sage Therapeutics's depression treatment, Sage-217, acts on GABA, one of the neurotransmitters in t…